Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
Chemical and Physical Biology Program, Vanderbilt University, Nashville, Tennessee, United States of America.
PLoS Comput Biol. 2023 Mar 27;19(3):e1010947. doi: 10.1371/journal.pcbi.1010947. eCollection 2023 Mar.
Lipid molecules such as cholesterol interact with the surface of integral membrane proteins (IMP) in a mode different from drug-like molecules in a protein binding pocket. These differences are due to the lipid molecule's shape, the membrane's hydrophobic environment, and the lipid's orientation in the membrane. We can use the recent increase in experimental structures in complex with cholesterol to understand protein-cholesterol interactions. We developed the RosettaCholesterol protocol consisting of (1) a prediction phase using an energy grid to sample and score native-like binding poses and (2) a specificity filter to calculate the likelihood that a cholesterol interaction site may be specific. We used a multi-pronged benchmark (self-dock, flip-dock, cross-dock, and global-dock) of protein-cholesterol complexes to validate our method. RosettaCholesterol improved sampling and scoring of native poses over the standard RosettaLigand baseline method in 91% of cases and performs better regardless of benchmark complexity. On the β2AR, our method found one likely-specific site, which is described in the literature. The RosettaCholesterol protocol quantifies cholesterol binding site specificity. Our approach provides a starting point for high-throughput modeling and prediction of cholesterol binding sites for further experimental validation.
脂质分子(如胆固醇)与整合膜蛋白(IMP)的表面相互作用的方式与药物样分子在蛋白质结合口袋中的方式不同。这些差异是由于脂质分子的形状、膜的疏水环境以及脂质在膜中的取向造成的。我们可以利用最近增加的与胆固醇复合的实验结构来理解蛋白质-胆固醇相互作用。我们开发了 RosettaCholesterol 协议,该协议包括(1)使用能量网格进行预测,以采样和评分天然样结合构象,(2)特异性过滤器,以计算胆固醇相互作用位点可能具有特异性的可能性。我们使用蛋白质-胆固醇复合物的多管齐下的基准(自对接、翻转对接、交叉对接和全局对接)来验证我们的方法。在 91%的情况下,RosettaCholesterol 改善了天然构象的采样和评分,优于标准的 RosettaLigand 基线方法,而且无论基准的复杂性如何,它的表现都更好。在β2AR 上,我们的方法找到了一个可能的特异性位点,这在文献中有描述。RosettaCholesterol 协议定量了胆固醇结合位点的特异性。我们的方法为进一步的实验验证提供了高通量建模和预测胆固醇结合位点的起点。